UPDATE: Citi Upgrades Vanda Pharmaceuticals (VNDA) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 3.79 -0.09 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.88 | 52 Week High | $18.00 | |||
| Open | $3.88 | 52 Week Low | $6.91 | |||
| Day High | $3.88 | P/E | N/A | |||
| Day Low | $3.73 | EPS | $-0.67 | |||
| Volume | 134,868 | |||||
